1. Home
  2. CRIS vs SPCB Comparison

CRIS vs SPCB Comparison

Compare CRIS & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • SPCB
  • Stock Information
  • Founded
  • CRIS 2000
  • SPCB 1988
  • Country
  • CRIS United States
  • SPCB Israel
  • Employees
  • CRIS N/A
  • SPCB N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • SPCB Semiconductors
  • Sector
  • CRIS Health Care
  • SPCB Technology
  • Exchange
  • CRIS Nasdaq
  • SPCB Nasdaq
  • Market Cap
  • CRIS 21.3M
  • SPCB 53.3M
  • IPO Year
  • CRIS 2000
  • SPCB N/A
  • Fundamental
  • Price
  • CRIS $1.80
  • SPCB $9.66
  • Analyst Decision
  • CRIS Strong Buy
  • SPCB Strong Buy
  • Analyst Count
  • CRIS 2
  • SPCB 1
  • Target Price
  • CRIS $16.50
  • SPCB $18.00
  • AVG Volume (30 Days)
  • CRIS 179.9K
  • SPCB 131.4K
  • Earning Date
  • CRIS 07-31-2025
  • SPCB 08-14-2025
  • Dividend Yield
  • CRIS N/A
  • SPCB N/A
  • EPS Growth
  • CRIS N/A
  • SPCB N/A
  • EPS
  • CRIS N/A
  • SPCB 1.89
  • Revenue
  • CRIS $11,202,000.00
  • SPCB $27,831,000.00
  • Revenue This Year
  • CRIS N/A
  • SPCB $2.73
  • Revenue Next Year
  • CRIS $10.67
  • SPCB $22.87
  • P/E Ratio
  • CRIS N/A
  • SPCB $5.20
  • Revenue Growth
  • CRIS 14.17
  • SPCB 2.90
  • 52 Week Low
  • CRIS $1.02
  • SPCB $2.55
  • 52 Week High
  • CRIS $8.29
  • SPCB $18.95
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 42.69
  • SPCB 45.50
  • Support Level
  • CRIS $1.70
  • SPCB $9.23
  • Resistance Level
  • CRIS $2.01
  • SPCB $11.00
  • Average True Range (ATR)
  • CRIS 0.21
  • SPCB 0.61
  • MACD
  • CRIS -0.03
  • SPCB -0.14
  • Stochastic Oscillator
  • CRIS 38.78
  • SPCB 22.99

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: